CS Medica A/S (NGM:CSMED) agreed to spin-off Cannordic A/S on June 10, 2024. The board members of CS MEDICA announced the approval to spin off 20% of its wholly-owned subsidiary CANNORDIC A/S. The extraordinary general assembly to approve this transaction is scheduled for June 2024. The transaction and stock market listing are planned to be completed by the end of 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.766 DKK | +0.22% |
|
-3.55% | +1.78% |
06-17 | CS Medica Completes Cannabidiol Medical Device Registration Process in Israel | MT |
06-12 | CS Medica to Boost Denmark Operations With OneMed Partnership | MT |
Annual profits - Rate of surprise
- Stock Market
- Equities
- CSMED Stock
- News CS MEDICA A/S
- CS Medica A/S agreed to Spin-Off Cannordic A/S.